AAAAAA
Results:
1-14
|
Results: 14
Authors:
Nerad, JL
Kessler, HA
Citation: Jl. Nerad et Ha. Kessler, Hypercholesterolemia in a health care worker receiving thyroxine after postexposure prophylaxis for human immunodeficiency virus infection, CLIN INF D, 32(11), 2001, pp. 1635-1636
Authors:
Murphy, RL
Brun, S
Hicks, C
Eron, JT
Gulick, R
King, M
White, AC
Benson, C
Thompson, M
Kessler, HA
Hammer, S
Bertz, R
Hsu, A
Japour, A
Sun, E
Citation: Rl. Murphy et al., ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results, AIDS, 15(1), 2001, pp. F1-F9
Authors:
Grene, H
Pinto, LA
Landay, AL
Kessler, HA
Anderson, SA
Dolan, MJ
Shearer, GM
Citation: H. Grene et al., Anti-CCR5 antibodies in sera of HIV-positive individuals, HUMAN IMMUN, 62(2), 2001, pp. 143-145
Authors:
Blazevic, V
Sahgal, N
Kessler, HA
Landay, AL
Shearer, GM
Citation: V. Blazevic et al., T cell responses to recall antigens, alloantigen, and mitogen of HIV-infected patients receiving long-term combined antiretroviral therapy, AIDS RES H, 16(17), 2000, pp. 1887-1893
Authors:
Grene, E
Pinto, LA
Kwak-Kim, JYH
Giorgi, JV
Landay, AL
Kessler, HA
Beer, AE
Shearer, GM
Citation: E. Grene et al., Increased levels of anti-CCR5 antibodies in sera from individuals immunized with allogeneic lymphocytes, AIDS, 14(16), 2000, pp. 2627-2628
Authors:
Tenorio, AR
Irlanda, IE
Narkiewicz, E
Smith, KY
Kessler, HA
Sha, BE
Citation: Ar. Tenorio et al., Efficacy and safety of the combination of efavirenz and abacavir in HIV-infected patients failing antiretroviral therapy, AIDS, 14(10), 2000, pp. 1470-1471
Authors:
Sha, BE
Proia, LA
Kessler, HA
Citation: Be. Sha et al., Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers, J AM MED A, 284(21), 2000, pp. 2723-2723
Authors:
Smith, KY
Valdez, H
Landay, A
Spritzler, J
Kessler, HA
Connick, E
Kuritzkes, D
Gross, B
Francis, I
McCune, JM
Lederman, MM
Citation: Ky. Smith et al., Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy, J INFEC DIS, 181(1), 2000, pp. 141-147
Authors:
Proia, LA
Ngui, SL
Kaur, S
Kessler, HA
Trenholme, GM
Citation: La. Proia et al., Reactivation of hepatitis B in patients with human immunodeficiency virus infection treated with combination antiretroviral therapy, AM J MED, 108(3), 2000, pp. 249-251
Authors:
D'Amico, R
Pinto, LA
Meyer, P
Landay, AL
Harris, AA
Clerici, M
Berzofsky, JA
Shearer, GM
Kessler, HA
Citation: R. D'Amico et al., Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers, INFECT CONT, 20(6), 1999, pp. 428-430
Authors:
Olivero, OA
Shearer, GM
Chougnet, CA
Kovacs, AAS
Landay, AL
Baker, R
Stek, AM
Khoury, MM
Proia, LA
Kessler, HA
Sha, BE
Tarone, RE
Poirier, MC
Citation: Oa. Olivero et al., Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero, AIDS, 13(8), 1999, pp. 919-925
Authors:
Irlanda, I
Kessler, HA
Citation: I. Irlanda et Ha. Kessler, HIV primary care, J AM MED A, 281(5), 1999, pp. 469-470
Authors:
Tack, PC
Bremer, JW
Harris, AA
Landay, AL
Kessler, HA
Kuritzkes, DR
Citation: Pc. Tack et al., Genotypic analysis of HIV-1 isolates to identify antiretroviral resistancemutations from source patients involved in health care worker occupationalexposures, J AM MED A, 281(12), 1999, pp. 1085-1086
Authors:
Chougnet, C
Cohen, SS
Kawamura, T
Landay, AL
Kessler, HA
Thomas, E
Blauvelt, A
Shearer, GM
Citation: C. Chougnet et al., Normal immune function of monocyte-derived dendritic cells from HIV-Infected individuals: Implications for immunotherapy, J IMMUNOL, 163(3), 1999, pp. 1666-1673
Risultati:
1-14
|